VANCOUVER, BC — Aequus Pharmaceuticals Inc. (TSX-V:AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing, and promoting differentiated products, reports financial results… Read More
VANCOUVER, BC — Xenon Pharmaceuticals Inc. (Nasdaq:XENE) (“Xenon”), a neurology-focused biopharmaceutical company, announced that it has commenced an underwritten public offering of $225.0 million of its common shares and, in… Read More
TORONTO, ON — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that Health Canada has granted Market Authorization for the expanded use of PrKALYDECO® (ivacaftor) for the treatment of cystic fibrosis (CF) in children ages 2 months… Read More
DELTA, BC — Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development. The Company is pleased to announce the receipt of its Controlled… Read More
INM-089 improves retinal function in in vivo preclinical AMD disease model Establishes cannabinol (CBN) analog candidate in a new disease target VANCOUVER, BC — InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the… Read More
